Literature DB >> 11428679

Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles.

M K Yeh1, S M Tung, D W Lu, J L Chen, C H Chiang.   

Abstract

Microparticles containing 5-fluorouracil (5-FU) were prepared using poly(DL-lactide-co-glycolide) with an oil-in-oil emulsion/solvent extraction technique. Particle characteristics including size distribution, 5-FU loading efficiencies, in vitro release and degradation were investigated. The dispersed phase was composed of PLG dissolved in dichloromethane, and the continuous phase was paraffin oil containing lecithin. 5-FU was successfully entrapped in the microparticles with trapping efficiencies up to 76%, loading level 10% w/v, and particle size 3 microm. Release profiles of 5-FU loaded microparticles were determined to follow a first-order-time relationship. An optimized preparation of 5-FU microparticles was achieved and was capable of controlling the release of 5-FU over 21 days with an in vitro delivery rate of 0.4 microg 5-FU/mg particles/day in the study. Preliminary animal studies indicated that the 5-FU loaded microparticles as an ocular delivery system showed no ocular toxicity and no significant inflammatory response in rabbits for 2 months. The 5-FU loaded microparticles approach, with PLG, might be a potential for the application of long-term delivery of hydrophilic drugs in the eye.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428679     DOI: 10.1080/02652040010018100

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  8 in total

1.  Paclitaxel-Releasing Thin Biodegradable Film for Prevention of Bleb Avascularity Without Compromising Filtration in Rabbits.

Authors:  Tetsuhiko Okuda; Tomomi Higashide; Mayumi Sakurai; Yukako Fukuhira; Hiroaki Kaneko; Masatsugu Shimomura; Kazuhisa Sugiyama
Journal:  Transl Vis Sci Technol       Date:  2015-06-11       Impact factor: 3.283

2.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

3.  Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes.

Authors:  Seham A Elkheshen; Rania M Hathout; Engy A Abdel Azim; Marwa A Fouly; Nada M El Hoffy
Journal:  Int J Nanomedicine       Date:  2022-06-25

4.  Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters.

Authors:  Rajesh H Parikh; Jolly R Parikh; Rajesh R Dubey; Heena N Soni; Kishor N Kapadia
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

5.  Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique.

Authors:  Sabyasachi Maiti; Paramita Dey; Santanu Kaity; Somasree Ray; Sushomasri Maji; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2009-05-29       Impact factor: 3.246

6.  Development of enteric submicron particle formulation of papain for oral delivery.

Authors:  Manu Sharma; Vinay Sharma; Amulya K Panda; Dipak K Majumdar
Journal:  Int J Nanomedicine       Date:  2011-09-23

7.  PEDF in diabetic retinopathy: a protective effect of oxidative stress.

Authors:  Xiao-feng Zhu; Hai-dong Zou
Journal:  J Biomed Biotechnol       Date:  2012-04-10

Review 8.  Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.

Authors:  José L Arias
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.